Jardy Met Xr 25/1000Ms 14s
Empagliflozin 25mg and metformin 1000mg XR for type 2 diabetes.
Jardy Met Xr 25/1000Ms 14s combines empagliflozin (SGLT2) 25mg and metformin 1000mg in extended-release formulation for type 2 diabetes when dual therapy is needed. Take once daily with a meal as directed; swallow whole.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when combination therapy is appropriate.
Ingredients
Empagliflozin 25mg and metformin hydrochloride 1000mg (extended-release) per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections. Avoid excessive alcohol.
Side Effects
Nausea, diarrhoea, urinary tract infections, genital mycotic infections. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | CCL |
| Status | Active |
Related Products
